Advancing novel, small molecule treatments targeting epigenetic mechanisms in tumor and immune cells for the benefit of patients.
Constellation is pursuing discovery programs against multiple targets in the reader, writer, and eraser classes of epigenetic proteins.
Constellation Pharmaceuticals, Inc.
215 First Street, Suite 200
Cambridge, MA 02142
For Media Inquiries
+1 (910) 509-3977
For General Inquires
To request additional information please use:
Phone: (617) 714-0555
Fax: (617) 577-0472